Ajulemic acid: A novel cannabinoid produces analgesia without a "high"

Life Sciences

Volumn 75, Issue 12, 2004, Pages 1513-1522

  Burstein, Sumner H ^a   Karst, Matthias ^b   Schneider, Udo ^b   Zurier, Robert B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Ajulemic acid; Cannabinoid; Inflammation; Pain

Indexed keywords

AJULEMIC ACID; CANNABINOID; DRUG METABOLITE; ICOSANOID; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PSYCHOTROPIC AGENT;

ANALGESIA; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DEPENDENCE; DRUG MECHANISM; DRUG STRUCTURE; DRUG WITHDRAWAL; HUMAN; HUMAN CELL; NEUROPATHIC PAIN; NONHUMAN; RAT; SIDE EFFECT; VISUAL ANALOG SCALE;

ANALGESICS; ANTI-INFLAMMATORY AGENTS; CANNABIS; DRUG DESIGN; PAIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TETRAHYDROCANNABINOL; TRANSCRIPTION FACTORS;

CANNABIS; DIOSCOREA TRIFIDA;

EID: 3042701554     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.04.010     Document Type: Article

References (28)

1. Bidinger B., Torres R., Rossetti R.G., Brown L., Beltre R., Burstein S., Lian J.B., Stein G.S., Zurier R.B. Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes. Clinical Immunology. 108:2003;95-102
2. Burstein S., Rosenfeld J., Wittstruck T. Isolation and characterization of two major urinary metabolites of 1-tetrahydrocannabinol. Science. 176:1972;422-423
3. Burstein S., Hunter S.A., Latham V., Renzulli L. Prostaglandins and cannabis-XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites. Biochemical Pharmacology. 35:1986;2553-2558
4. Burstein S. Therapeutic Potential of Ajulemic Acid (CT-3). Grotenhermen F. Cannabis and Cannabinoids. 2002;381-388 Haworth Press, New York
5. Burstein S.H. Inhibitory and stimulatory effects of cannabinoids on eicosanoid synthesis. NIDA Research Monograph. 79:1987;158-172
6. Burstein S.H., Hull K., Hunter S.A., Latham V. Cannabinoids and pain responses: a possible role for prostaglandins. FASEB Journal. 2:1988;3022-3026
7. Burstein S.H., Audette C.A., Breuer A., Devane W.A., Colodner S., Doyle S.A., Mechoulam R. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities. Journal of Medicinal Chemistry. 35:1992;3135-3141
8. Burstein S.H., Friderichs E., Kogel B., Schneider J., Selve N. Analgesic effects of 1′, 1′ dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice. Life Sciences. 63:1998;161-168
9. Burstein S.H. The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. Pharmacology and Therapeutics. 82:1999;87-96
10. Burstein S.H. Ajulemic acid (CT3): a potent analog of the acid metabolites of THC. Current Pharmaceutical Design. 6:2000;1339-1345
11. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. Journal of Pharmacology and Experimental Therapeutics. 265:1993;218-226
12. Dajani E.Z., Larsen K.R., Taylor J., Dajani N.E., Shahwan T.G., Neeleman S.D., Taylor M.S., Dayton M.T., Mir G.N. 1′, 1′-Dimethylheptyl- delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties. Journal of Pharmacology and Experimental Therapeutics. 291:1999;31-38
13. Espinoza-Delgado I., Bosco M.C., Musso T., Gusella G.L., Longo D.L., Varesio L. Interleukin-2 and human monocyte activation. Journal of Leukocyte Biology. 57:1995;13-19
14. Joosten L.A., Helsen M.M., Saxne T., van De Loo F.A., Heinegard D., van Den Berg W.B. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. Journal of Immunology. 163:1999;5049-5055
15. Karst M., Salim K., Burstein S., Conrad I., Hoy L., Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA. 290:2003;1757-1762
16. Liu J., Li H., Burstein S.H., Zurier R.B., Chen J.D. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Molecular Pharmacology. 63:2003;983-992
17. Loev B., Bender P.E., Dowalo F., Macko E., Fowler P.J. Cannabinoids. Structure-activity studies related to 1, 2-dimethylheptyl derivatives. Journal of Medicinal Chemistry. 16:1973;1200-1206
18. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365
19. Nakajima T., Aono H., Hasunuma T., Yamamoto K., Shirai T., Hirohata K., Nishioka K. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis and Rheumatism. 38:1995;485-491
20. Panayi G.S., Lanchbury J.S., Kingsley G.H. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis and Rheumatism. 35:1992;729-735
21. Perez-Reyes, M., 1985. Pharmacodynamics of certain drugs of abuse, 287-310.
22. Recht L.D., Salmonsen R., Rosetti R., Jang T., Pipia G., Kubiatowski T., Karim P., Ross A.H., Zurier R., Litofsky N.S., Burstein S. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. Biochemical Pharmacology. 62:2001;755-763
23. Rhee M.H., Vogel Z., Barg J., Bayewitch M., Levy R., Hanus L., Breuer A., Mechoulam R. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. Journal of Medicinal Chemistry. 40:1997;3228-3233
24. Sumariwalla P.F., Gallily R., Tchilibon S., Fride E., Mechoulam R., Feldmann M. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis. Arthritis and Rheumatism. 50:2004;985-998
25. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316
26. Yamamoto I., Kimura T., Kamei A., Yoshida H., Watanabe K., Ho I.K., Yoshimura H. Competitive inhibition of delta8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding. Biological and Pharmaceutical Bulletin. 21:1998;408-410
27. Zurier R.B., Rossetti R.G., Lane J.H., Goldberg J.M., Hunter S.A., Burstein S.H. Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure. Arthritis and Rheumatism. 41:1998;163-170
28. Zurier R.B., Rossetti R.G., Burstein S.H., Bidinger B. Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid. Biochemical Pharmacology. 65:2003;649-655